Problems discovered in drug clinical trial quality monitoring and countermeasures: including problems of post-marketing reevaluation of Chinese patent drugs

LI Jing; SHANG Hong-cai; ZHAO Chen

doi:10.3969/j.issn.1003-3734.2019.18.002

Home>Articles>Problems discovered in drug clinical trial quality monitoring and countermeasures: including problems of post-marketing reevaluation of Chinese patent drugs

DOI: 10.3969/j.issn.1003-3734.2019.18.002

Problems discovered in drug clinical trial quality monitoring and countermeasures: including problems of post-marketing reevaluation of Chinese patent drugs

LI Jing

SHANG Hong-cai

ZHAO Chen

Machine-generated Keywords：

Publication Date：2019-01-01

Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)

Pages：5( 2184-2188 )

Chinese Journal of New Drugs

PKUISTIC

ISSN：1003-3734

Year, Vol.(Issue)：2019,28(18)